Edmonton, Canada

Ronald N McElhaney

This inventor holds 1 USPTO granted patent. Top assignee: Pence, Inc.. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ronald N McElhaney

Introduction

Ronald N McElhaney is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of antimicrobial research through his innovative work on peptide compositions. His dedication to advancing medical science is evident in his patented inventions.

Latest Patents

McElhaney holds a patent for "Antimicrobial peptide compositions and method." This invention focuses on antimicrobial cyclic peptides and peptide analogs that exhibit relatively low hemolytic activity. The peptides developed by McElhaney are effective in killing and inhibiting the growth of various microorganisms, including gram-positive bacteria, gram-negative bacteria, fungi, and mycoplasma. The patent also discloses methods for inhibiting or killing these microorganisms, along with therapeutic preparations for such purposes.

Career Highlights

Throughout his career, Ronald N McElhaney has been associated with Pence, Inc., where he has furthered his research and development efforts. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications in medicine.

Collaborations

Some of McElhaney's notable coworkers include Leslie H Kondejewski and Robert S Hodges. Their collaborative efforts have likely enhanced the research and development processes within their field.

Conclusion

Ronald N McElhaney's contributions to antimicrobial research through his innovative peptide compositions highlight his role as a significant inventor. His work continues to impact the medical field positively, showcasing the importance of innovation in addressing microbial challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…